Monoclonal antibodies to avermectins
CA 2039541 A1 · Owner: Jacobson, Ethel B. · Inventors: Jacobson, Ethel B.; Marburg, Stephen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel monoclonal antibodies immunospecific for compounds of the avermectin complex are disclosed. A unique hybridoma cell line which produces the immunospecific monoclonal antibodies. The anti-avermectin monoclonal antibodies are used therapeutically to treat avermectin poisoning and serologically to identify and quantitate avermectins in animal body fluids.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 2, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 2, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 2, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.